Drug Shortage Report for ROCURONIUM BROMIDE INJECTION

Last updated on 2018-02-10 History
Report ID 30511
Drug Identification Number 02318121
Brand name ROCURONIUM BROMIDE INJECTION
Common or Proper name ROCURONIUM BROMIDE
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ROCURONIUM BROMIDE
Strength(s) 10MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10x5mL
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-07
Estimated end date
Actual end date 2018-02-09
Shortage status Resolved
Updated date 2018-02-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-11-23 English Compare
v2 2017-11-23 French Compare
v3 2017-12-06 English Compare
v4 2017-12-06 English Compare
v5 2017-12-06 French Compare
v6 2017-12-15 English Compare
v7 2017-12-15 French Compare
v8 2018-02-09 English Compare
v9 2018-02-09 French Compare
v10 2018-02-10 English Compare

Showing 1 to 10 of 10